- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01744145
Effect of Exercise and Education After Pneumonia (EPICC)
Early Pneumonia Intervention to Prevent Chronic Complications in Patients Age 40 and Above
The mortality rate and quality of life is effected in patients with pneumonia, especially in the older population.
The end point of this study is to improve quality of life by and interventional exercise and education. Patients will be randomized at admission and enrolled into the study. They will be assessed with various performance and quality of life indicators before, during and after the study, and exercise tolerance will be assessed throughout and after.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Mineola, New York, United States, 11501
- Winthrop University Hosptial
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of CAP or HCAP via radiographic imaging and symptoms of pneumonia Age 40 and above.
- Discharge to home.
- Ability to read and sign consent.
- Ability to perform in procedures/exercise.
- Ability to understand educational component of the program.
- Antibiotic administration for pneumonia within 12 hours of admission.
Exclusion Criteria:
- Severe lung diseases like ILD(Interstitial Lung disease), ARDS (Adult Respiratory Distress Syndrome.)
- Ventilator dependent patients.
- Discharge to nursing home.
- Comorbidity that could limit exercise training.
- Dementia, Schizophrenia or any active severe psychiatric disorder.
- Any Active Malignancy or diagnosis of Lung malignancy.
- Inability to attend program two times per week.
- Recent myocardial infarction within two months.
- Unstable angina, Heart failure (NYHA class III and IV.)
- Patients with pneumonia who did not receive antibiotics within 12 hours of admission.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Interventional 40-60
Interventional group aged 40-60
|
This group will receive the intervention aged 40-60
|
|
Active Comparator: Interventional 60 and above
Interventional group aged 60 and above
|
This group will receive the intervention aged 60 and above.
|
|
No Intervention: Control 40-60
Control group aged 40-60
|
|
|
No Intervention: Control 60 and above
Control group aged 60 and above
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
improvement in quality of life indices
Time Frame: one year
|
patients in the interventional group will undergo exercise and education after a pneumonia infection to see if the quality of life is effected by a rehab program
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
improvement in functional status
Time Frame: one year
|
one year
|
|
|
change in 6 minute walk test
Time Frame: one year
|
one year
|
|
|
exercise intolerance
Time Frame: one year
|
one year
|
|
|
immunization
Time Frame: one year
|
Patients will be assessed to see if education offered in the interventional group will effect compliance with vaccination.
|
one year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Shalinee Chawla, MD, Winthrop University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 255021-4
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Biomedical Advanced Research and Development AuthorityWithdrawnHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Universidad de la SabanaClínica Universidad de La Sabana; Universidad de La Sabana, ColombiaCompletedPneumococcal Pneumonia | Community Acquired Pneumonia (CAP)Colombia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
ShionogiCompletedHospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)Israel, Spain, United States, Belgium, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Japan, Latvia, Philippines, Puerto Rico, Russian Federation, Serbia, Taiwan, Ukraine
Clinical Trials on Interventional 40-60
-
Region Örebro CountyRecruitingMechanical Ventilation | Atelectasis | Distribution of VentilationSweden
-
Aarhus University HospitalOdense University Hospital; Zealand University Hospital; Rigshospitalet, Denmark and other collaboratorsCompletedAtrial Fibrillation | Sinus Node DiseaseDenmark
-
Kangbuk Samsung HospitalCompletedGynecologic DiseasesKorea, Republic of
-
Masarykova Nemocnice v Usti nad Labem, Krajska...Not yet recruitingDifficult Airway | Laryngoscopy | Airway Complication of Anaesthesia | High Flow Nasal Canula | Airway Anesthesia | Difficult / Failed Intubation
-
Cairo UniversityCompleted
-
S-INFINITY Pharmaceuticals Co., LtdNot yet recruiting
-
University of BolognaIpsen; Bioikos Ambiente Srl; AOU S.Orsola Malpighi-Unit of Oncologic Molecular... and other collaboratorsUnknownNon Small Cell Lung CancerItaly
-
Norwegian University of Science and TechnologyOslo University Hospital; University Hospital of North Norway; Sorlandet Hospital... and other collaboratorsActive, not recruitingSmall Cell Lung CarcinomaDenmark, Sweden, Norway
-
Institute of Sport - National Research Institute...Hitit University, Corum, TurkeyCompleted
-
Caliway Biopharmaceuticals Co., Ltd.Completed